# Gan & Lee Pharmaceuticals.

Organization · id `cardio:org-gan-lee-pharmaceuticals` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Gan+%26+Lee+Pharmaceuticals.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Gan & Lee Pharmaceuticals.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise (`cardio:ct-nct06777238`)
- Sponsors: A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus (`cardio:ct-nct06778967`)
- Sponsors: A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid (`cardio:ct-nct06780410`)
- Sponsors: Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes (`cardio:ct-nct07387003`)
- Sponsors: Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes (`cardio:ct-nct07527078`)

## Provenance

Content hash: 5d9b17e81c770f4659ecdbb4ffd4680f9f2c4deba380d9b3bd6fa01aef063f17
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
